Kohichiro Yoshino
President bei CARNA BIOSCIENCES, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Kohichiro Yoshino is currently the President & Representative Director at Carna Biosciences, Inc. He is also an Independent Outside Director at MEDINET Co., Ltd., CarnaBio USA, Inc., and Kringle Pharma, Inc. Previously, he served as the President & Representative Director at ProbeX, Inc. Yoshino holds a doctorate degree from Kyoto University and a graduate degree from Tokyo Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CARNA BIOSCIENCES, INC.
1,89% | 31.12.2022 | 324 100 ( 1,89% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Kohichiro Yoshino
| Unternehmen | Position | Beginn |
|---|---|---|
| CARNA BIOSCIENCES, INC. | President | 10.04.2003 |
| MEDINET CO., LTD. | Director/Board Member | 01.12.2018 |
| KRINGLE PHARMA, INC. | Director/Board Member | 01.12.2018 |
CarnaBio USA, Inc.
 CarnaBio USA, Inc. Medical DistributorsDistribution Services CarnaBio USA, Inc. provides biologicals and allied products. The company is headquartered in Natick, MA. | Director/Board Member | 01.03.2011 |
Ehemalige bekannte Positionen von Kohichiro Yoshino
| Unternehmen | Position | Ende |
|---|---|---|
ProbeX, Inc.
 ProbeX, Inc. Medical/Nursing ServicesHealth Services Part of Carna Biosciences, Inc., ProbeX, Inc. is a Japanese company that develops, manufactures, and distributes molecular imaging probe reagents. The private company is based in Tokyo, Japan. ProbeX was acquired by Carna Biosciences, Inc. from Life Science Management, Inc. on October 01, 2013 for $2.82 million. | President | - |
Ausbildung von Kohichiro Yoshino
| Kyoto University | Doctorate Degree |
| Tokyo Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CARNA BIOSCIENCES, INC. | Health Technology |
| MEDINET CO., LTD. | Health Technology |
| KRINGLE PHARMA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
CarnaBio USA, Inc.
CarnaBio USA, Inc. Medical DistributorsDistribution Services CarnaBio USA, Inc. provides biologicals and allied products. The company is headquartered in Natick, MA. | Distribution Services |
ProbeX, Inc.
ProbeX, Inc. Medical/Nursing ServicesHealth Services Part of Carna Biosciences, Inc., ProbeX, Inc. is a Japanese company that develops, manufactures, and distributes molecular imaging probe reagents. The private company is based in Tokyo, Japan. ProbeX was acquired by Carna Biosciences, Inc. from Life Science Management, Inc. on October 01, 2013 for $2.82 million. | Health Services |
